NEO:NASDAQ
NeoGenomics, Inc.
18,57 $
arrow_downward
-0,91%(-0,17) 1D
30 սեպ, 14:33:23 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
18,76 $
High
18,96 $
Low
18,45 $
Mkt. cap
2,39 մլրդ
Avg. vol.
1,96 մլն
Volume
616,09 հզր
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
Open
18,76 $
High
18,96 $
Low
18,45 $
Mkt. cap
2,39 մլրդ
Avg. vol.
1,96 մլն
Volume
616,09 հզր
52-wk high
20,05 $
52-wk low
7,06 $
EPS
-0,40 $
Beta
1,75
Shares outstanding
128,48 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
AD HOC NEWS
·
1 օր առաջ
NeoGenomics stock trades at EUR 17.04 after Q2 EPS beat
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2,5 հզր
Founded2002
HeadquartersՖորտ Մայերս, Ֆլորիդա, Միացյալ Նահանգներ
SectorHealth care provider
Websiteneogenomics.com